Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Linuron SCHEMBL9100946 | 0.88 | KMT2A (0.58) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL29349863 | 0.84 | APEX1 (1.00) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL1352353 | 0.84 | APEX1 (1.00) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL7279 | 0.84 | APEX1 (1.00) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL5810138 | 0.83 | APEX1 (0.90) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL28964105 | 0.83 | APEX1 (0.96) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL20723892 | 0.83 | APEX1 (0.96) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL20723673 | 0.83 | APEX1 (0.96) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL10491599 | 0.83 | APEX1 (0.96) | APEX1GAAALDH1A1KDM4EGLA | |
| Dcmu SCHEMBL28379561 | 0.83 | APEX1 (0.96) | APEX1GAAALDH1A1KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180235992-A1 | IMMUNOTHERAPIES FOR MALIGNANT, NEURODEGENERATIVE AND DEMYELINATING DISEASES BY THE USE OF TARGETED NANOCARRIERS | RODOS BIOTARGET GMBH (DE) | 2018-08-23 | — | — | US | disclosed |
| EP-3328367-A1 | IMMUNOTHERAPIES FOR MALIGNANT, NEURODEGENERATIVE AND DEMYELINATING DISEASES BY THE USE OF TARGETED NANOCARRIERS | Rodos BioTarget GmbH (DE) | 2018-06-06 | — | — | EP | disclosed |
| WO-2017017148-A1 | IMMUNOTHERAPIES FOR MALIGNANT, NEURODEGENERATIVE AND DEMYELINATING DISEASES BY THE USE OF TARGETED NANOCARRIERS | RODOS BIOTARGET GMBH (DE) | 2017-02-02 | — | — | WO | disclosed |
| US-20100105640-A1 | Aromatase Inhibitors for Emergency Contraception | CASPER ROBERT F | 2010-04-29 | — | — | US | disclosed |
| EP-1898923-A4 | AROMATASE INHIBITORS FOR EMERGENCY CONTRACEPTION | CASPER ROBERT F (CA) | 2009-05-20 | — | — | EP | disclosed |
| US-20080207733-A1 | Composition for the Treatment of Vitiligo | CENTRO DE HISTOTERAPIA PLACENTARIA (CU) | 2008-08-28 | — | — | US | disclosed |
| EP-1898923-A1 | AROMATASE INHIBITORS FOR EMERGENCY CONTRACEPTION | Casper, Robert F. (CA) | 2008-03-19 | — | — | EP | disclosed |
| EP-1661565-B1 | COMPOSITION COMPRISING L-PROLINE FOR THE TREATMENT OF VITILIGO | CT DE HISTOTERAPIA PLACENTARIA (CU) | 2007-10-24 | — | — | EP | disclosed |
| EP-1217884-B1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2007-02-21 | — | — | EP | disclosed |
| WO-2007000056-A1 | AROMATASE INHIBITORS FOR EMERGENCY CONTRACEPTION | CASPER ROBERT F (CA) | 2007-01-04 | — | — | WO | disclosed |
| EP-1661565-A1 | COMPOSITION FOR THE TREATMENT OF VITILIGO | Centro de Histoterapia Placentaria (CU) | 2006-05-31 | — | — | EP | disclosed |
| US-6897065-B1 | Method for maturation of conifer somatic embryos | WOODY PLANT BIOTECH APS (DK) | 2005-05-24 | — | — | US | disclosed |
| WO-2005011676-A1 | COMPOSITION FOR THE TREATMENT OF VITILIGO | CENTRO DE HISTOTERAPIA PLACENTARIA (CU) | 2005-02-10 | — | — | WO | disclosed |
| EP-1217884-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | Woody Plant Biotech APS (DK) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180235992-A1 | IMMUNOTHERAPIES FOR MALIGNANT, NEURODEGENERATIVE AND DEMYELINATING DISEASES BY THE USE OF TARGETED NANOCARRIERS | MAG, MSR1, CD47 | APEX1 4240/4885GAA 610/4885ALDH1A1 3519/4885 |
| US-20100105640-A1 | Aromatase Inhibitors for Emergency Contraception | CYP19A1, SHBG, HSD17B11 | APEX1 299/4885GAA 2943/4885ALDH1A1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.